The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription

Chao-Kai Chou1, Dung-Fang Lee, Hui-Lung Sun

  • 1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Insights

AKT phosphorylation inhibits MAX dimerization protein 1 (MAD1) transcription suppression. This process, crucial in cancer cells, activates target gene transcription, promoting cell growth by altering MYC binding dynamics.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • MAX dimerization protein 1 (MAD1) suppresses transcription by competing with MYC for promoter binding sites, influencing cell proliferation and differentiation.
  • The regulation of MAD1, particularly in cancer cells, remains poorly understood.
  • MYC and MAD1 dynamics at gene promoters are critical for cellular processes.

Purpose of the Study:

  • To investigate the regulatory mechanism of MAD1 in cancer cells.
  • To elucidate the role of AKT signaling in modulating MAD1's transcriptional repressive function.
  • To understand how AKT-mediated phosphorylation affects MAD1's interaction with target gene promoters.

Main Methods:

  • Co-immunoprecipitation to demonstrate physical interaction between AKT and MAD1.
  • In vitro kinase assays to confirm AKT-mediated phosphorylation of MAD1.
  • Site-directed mutagenesis (S145A) to assess the role of phosphorylation.
  • Quantitative PCR and reporter assays to measure target gene transcription (hTERT, ODC).
  • Cell cycle analysis and cell proliferation assays.

Main Results:

  • AKT physically interacts with and phosphorylates MAD1.
  • Phosphorylation of MAD1 by AKT reduces its DNA-binding affinity, abolishing transcription repression.
  • Mutation of the phosphorylation site (S145A) abrogates AKT-mediated inhibition.
  • AKT promotes cell cycle progression and growth by inhibiting MAD1-mediated repression of target genes like hTERT and ODC.

Conclusions:

  • AKT-mediated phosphorylation of MAD1 is a key regulatory mechanism that inhibits its transcriptional suppressor activity.
  • This phosphorylation event releases the repression of MAD1 target genes, thereby promoting cell cycle progression and growth in cancer cells.
  • Targeting the AKT-MAD1 interaction could offer a novel therapeutic strategy in cancers where this pathway is dysregulated.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...